Benzodiazepines treat alcohol withdrawal via allosteric enhancement of postsynaptic GABA-A channels
Know this
Alcohol withdrawal = downregulated GABA-A + upregulated NMDA; treat with benzodiazepines (↑ GABA-A Cl⁻ opening frequency; use oxazepam/temazepam/lorazepam if palmar erythema/cirrhosis).
Why it works
Chronic ethanol exposure persistently potentiates inhibitory GABA_A chloride channels and inhibits excitatory NMDA glutamate receptors. To maintain homeostatic balance, central neurons downregulate postsynaptic GABA_A receptors and upregulate NMDA receptors. When ethanol is abruptly withdrawn, unopposed glutamatergic excitation and collapsed GABAergic tone unleash tremors, autonomic storm, withdrawal seizures (12–48 hours), and delirium tremens (48–96 hours). First-line benzodiazepines substitute via cross-tolerance: binding between α and γ subunits of postsynaptic GABA_A ionotropic receptors, they increase the frequency of Cl⁻ channel opening in response to endogenous GABA, hyperpolarizing neurons before a controlled taper.
Choosing the right benzodiazepine in hepatic disease
Long-acting benzodiazepines (chlordiazepoxide, diazepam) provide smooth self-tapering via active hepatic CYP450 metabolites in patients with healthy livers. However, when physical signs such as palmar erythema, spider angiomata, or ascites signal cirrhosis, phase I oxidation fails and active metabolites accumulate, risking coma and respiratory depression. In liver disease or advanced age, choose oxazepam, temazepam, or lorazepam, which undergo direct phase II glucuronidation with no active metabolites.
Alcohol withdrawal timeline & relapse-prevention drugs
Withdrawal unfolds predictably after the last drink: 6–24 hours brings anxiety, insomnia, diaphoresis, tachycardia, and coarse tremor; 12–48 hours brings generalized tonic-clonic seizures and alcoholic hallucinosis (visual/tactile hallucinations with intact orientation); 48–96 hours brings delirium tremens (profound disorientation, agitation, fever, autonomic instability, and mortality risk). After acute detoxification, naltrexone (μ-opioid antagonist), acamprosate (NMDA modulator), or disulfiram (aldehyde dehydrogenase inhibitor) helps maintain abstinence.
Commonly confused
- Increased GABA transaminase activity: GABA transaminase catabolizes synaptic GABA into succinic semialdehyde, which would lower inhibitory tone and worsen withdrawal seizures. Antiepileptics like valproate and vigabatrin inhibit GABA transaminase to raise GABA levels.
- Opening of glutamate channels or inhibition of glutamate release: Opening excitatory NMDA or AMPA channels would precipitate status epilepticus during hyperglutamatergic alcohol withdrawal, while glutamate-release inhibitors (such as lamotrigine or riluzole) are used for epilepsy/bipolar maintenance or ALS rather than acute alcohol detoxification.
- Blockade of dopamine receptors: First-generation antipsychotics like haloperidol block D₂ receptors to calm psychotic agitation in general delirium, but in alcohol withdrawal monotherapy they fail to correct GABA-A deficiency and dangerously lower the seizure threshold.
- Inhibition of serotonin reuptake or decreased dopamine transporter activity: SSRIs block SERT for depressive/anxiety disorders and bupropion/stimulants inhibit DAT for depression, smoking cessation, or ADHD; bupropion is strictly contraindicated in patients with alcohol withdrawal or prior seizures because it provokes seizures.
Check yourself
How does the single-channel gating mechanism of benzodiazepines differ from barbiturates at the GABA-A receptor?